Aligos Therapeutics Inc (ALGS)

15.19 -1.08  -6.64% NASDAQ Nov 29, 16:00 15.27 +0.08  +0.53% After-Hours: 20:00 USD

Aligos Therapeutics Cash from Operations (TTM):

-97.87M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Operations (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Operations (TTM) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 -97.87M
June 30, 2021 -89.06M
March 31, 2021 -83.74M
Dec. 31, 2020 -74.26M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Benchmarks

CEL-SCI Corp -17.57M
AIM ImmunoTech Inc -11.07M
NovaBay Pharmaceuticals Inc -6.319M

Cash from Operations (TTM) Range, Past 5 Years

Minimum -97.87M Sep 2021
Maximum -74.26M Dec 2020
Average -86.23M





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.